Mycophenolate mofetil Recruiting Phase 2 Trials for Focal Segmental Glomerulosclerosis (FSGS) / Transplantation, Kidney Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02921789Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients